<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0015">
 <label>Table 3</label>
 <caption>
  <p>Summary of potential peptide therapies for SARS.</p>
 </caption>
 <alt-text id="at0025">Table 3</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Peptide Name</th>
    <th align="left">Sequence</th>
    <th align="left">Derived from</th>
    <th align="left">Target</th>
    <th align="left">IC
     <sub>50</sub>
    </th>
    <th align="left">Assay Format Tested</th>
    <th align="left">Phase</th>
    <th align="left">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">P8</td>
    <td align="left">PSSKRFQPFQQFGRDVSDFT</td>
    <td align="left">S protein</td>
    <td align="left">ACE2 receptor</td>
    <td align="left">*</td>
    <td align="left">Syncytia inhibition assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0665" ref-type="bibr">133</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">P9</td>
    <td align="left">CANLLLQYGSFCTQLNRALSGIA</td>
    <td align="left">S protein</td>
    <td align="left">ACE2 receptor</td>
    <td align="left">*</td>
    <td align="left">Syncytia inhibition assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0665" ref-type="bibr">133</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">P2</td>
    <td align="left">PTTFMLKYDENGTITDAVDC</td>
    <td align="left">S protein</td>
    <td align="left">ACE2 receptor</td>
    <td align="left">112.5 μg /mL, (IC90)</td>
    <td align="left">Cytopathic effect (CPE)-based assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib1160" ref-type="bibr">232</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">P6</td>
    <td align="left">YQDVNCTDVSTAIHADQLTP</td>
    <td align="left">S protein</td>
    <td align="left">ACE2 receptor</td>
    <td align="left">113.0 μg /mL, (IC90)</td>
    <td align="left">Cytopathic effect (CPE)-based assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib1160" ref-type="bibr">232</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">P8</td>
    <td align="left">QYGSFCTQLNRALSGIAAEQ</td>
    <td align="left">S protein</td>
    <td align="left">ACE2 receptor</td>
    <td align="left">24.9 μg /mL, (IC90)</td>
    <td align="left">Cytopathic effect (CPE)-based assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib1160" ref-type="bibr">232</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">P10</td>
    <td align="left">IQKEIDRLNEVAKNLNESLI</td>
    <td align="left">S protein</td>
    <td align="left">ACE2 receptor</td>
    <td align="left">73.5 μg /mL, (IC90)</td>
    <td align="left">Cytopathic effect (CPE)-based assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib1160" ref-type="bibr">232</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">S
     <sub>471−503</sub>
    </td>
    <td align="left">ALNCYWPLNDYGFYTTTGIGYQPYRWVLSFEL</td>
    <td align="left">S protein</td>
    <td align="left">ACE2 receptor</td>
    <td align="left">*</td>
    <td align="left">Competition ELISA, plaque assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0475" ref-type="bibr">95</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">SNA5</td>
    <td align="left">GGGWFCPIVRGRVSC</td>
    <td align="left">Phage display library</td>
    <td align="left">N protein</td>
    <td align="left">n/a</td>
    <td align="left">Monoclonal phage ELISA</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0640" ref-type="bibr">128</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">octapeptide</td>
    <td align="left">AVLQSGFR</td>
    <td align="left">Structure-based drug design and modeling</td>
    <td align="left">M
     <sup>pro</sup>
    </td>
    <td align="left">2.7 × 10
     <sup>−2</sup> mg/L
    </td>
    <td align="left">Cytopathic effect (CPE)-based assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0195" ref-type="bibr">39</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">P9</td>
    <td align="left">NGAICWGPCPTAFRQIGNCGHFKVRCCKIR</td>
    <td align="left">β-defensin-4</td>
    <td align="left">Endosome acidification</td>
    <td align="left">5 μg/mL</td>
    <td align="left">plaque reduction assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib1155" ref-type="bibr">231</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>*not available in the literature.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
